Precision medicine is an emerging approach for disease treatment. Big value is given to these companies in the US. Its only a matter of time the investors on the ASX find us. $25M market cap at 12c share price is quite low imo considering the newsflow over the next 12months . Over $20m has already been spent on drug development and trials i believe.
Chart looks good on daily and weekly trends. We may see a high of 15c this month if we get someone looking to acquire some volume. Even at 15c the market cap is only $31m . Im certainly not handing over any shares at that price. PTX is tightly held so its going to have to go past 15c to shake out bigger volume imo.
PTX Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
